Jan Geliebter
Affiliations: | Microbiology and Immunology | New York Medical College, New York, NY, United States |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Jan Geliebter"Children
Sign in to add traineeChristina D. Zeoli | grad student | 2001 | New York Medical College |
Niradiz d. Reyes Ramos | grad student | 2003 | New York Medical College |
Theodore S. Nowicki | grad student | 2013 | New York Medical College |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gupta A, Carnazza M, Jones M, et al. (2023) Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells. Cancers. 15 |
Dadafarin S, Rodríguez TC, Carnazza MA, et al. (2022) Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer. Cells. 11 |
Dadafarin S, Carnazza M, Islam HK, et al. (2021) Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis. Advances in Experimental Medicine and Biology. 1350: 145-155 |
Chakraborty S, Carnazza M, Jarboe T, et al. (2021) Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity. Advances in Experimental Medicine and Biology. 1350: 33-66 |
Jarboe T, Tuli NY, Chakraborty S, et al. (2021) Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers. Advances in Experimental Medicine and Biology. 1350: 1-31 |
Jones ME, O'Connell TJ, Zhao H, et al. (2021) Androgen receptor activation decreases proliferation in thyroid cancer cells. Journal of Cellular Biochemistry |
Reyes N, Bettin A, Geliebter J. (2020) Abstract 748: The small leucine-rich proteoglycan fibromodulin is a potential, novel serum and urinary biomarker for the detection of prostate cancer Clinical Trials |
Reyes N, Tiwari R, Geliebter J. (2020) Abstract 5591: Differential profiles of pro-inflammatory chemokines identified in patients with prostate cancer and benign prostatic hyperplasia Immunology. 80: 5591-5591 |
Dadafarin S, Carnazza MA, Moscatello A, et al. (2020) Abstract 2236: Mechanism of androgen-mediated down-regulation of PD-L1 in thyroid cancer Immunology. 80: 2236-2236 |
Chakraborty S, Jarboe T, Dadafarin S, et al. (2020) Abstract 2235: Implications of HVEM/BTLA/LIGHT signaling in anaplastic thyroid cancer Immunology |